BIM
ASTX

BlackRock Investment Management’s ASTEX PHARMACEUTICALS, INC COM ASTX Stock Holding History

BlackRock Investment Management’s Portfolio ASTX Stock Details ASTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		– Sell
-319,703
Closed -$2.71M – 3480
2013
Q3 		$2.71M Buy
319,703
+532
+0.2% +$3.37K ﹤0.01% 1729
2013
Q2 		$1.31M Buy
+319,171
New +$1.72M ﹤0.01% 2175

BlackRock Investment Management's ASTX Position: Q4 2013 in Review

BlackRock Investment Management sold out of ASTEX PHARMACEUTICALS, INC COM (ASTX) in Q4 2013, closing a stake of 319,703 shares — an estimated $2.71M sold.

BlackRock Investment Management first reported a position in ASTX in Q2 2013 and held it in 2 quarters. The position peaked at $2.71M in Q3 2013. 0 funds tracked by Wall St. Rank hold ASTX as of Q4 2013.

  • BlackRock Investment Management reported no remaining ASTEX PHARMACEUTICALS, INC COM position as of Q4 2013 after selling out during the quarter.
  • BlackRock Investment Management sold 319,703 ASTEX PHARMACEUTICALS, INC COM shares in Q4 2013, an estimated $2.71M.
  • BlackRock Investment Management first reported a position in ASTEX PHARMACEUTICALS, INC COM in Q2 2013 and held it in 2 quarters.
  • BlackRock Investment Management's ASTEX PHARMACEUTICALS, INC COM position peaked at $2.71M in Q3 2013.
  • 0 funds tracked by Wall St. Rank held ASTEX PHARMACEUTICALS, INC COM as of Q4 2013.

Based on BlackRock Investment Management's 13F filing for Q4 2013, filed 12 Feb 2014.